TherapeuticsMD
TXMD
#10631
Rank
C$33.44 M
Marketcap
C$2.89
Share price
0.04%
Change (1 day)
94.55%
Change (1 year)

EPS for TherapeuticsMD (TXMD)

EPS in 2026 (TTM): C$0.009509

According to TherapeuticsMD's latest financial reports the company's current EPS (TTM) is C$0.01395. In 2021 the company made an earnings per share (EPS) of C-$30.28 an increase over its 2020 EPS that were of C-$46.74.

EPS history for TherapeuticsMD from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$0.009509
2021C-$30.28-35.22%
2020C-$46.74-5.63%
2019C-$49.5320.34%
2018C-$41.1655.26%
2017C-$26.51-19.15%
2016C-$32.79-6%
2015C-$34.8842.86%
2014C-$24.4252.17%
2013C-$16.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.83 13,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$2.87 20,468.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
C-$5.40-38,800.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
C$2.66 18,948.80%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
C-$35.27-252,900.00%๐Ÿ‡บ๐Ÿ‡ธ USA